- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the Notch signaling in cholangiocarcinoma
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 21, Issue 5, Pages 471-483
Publisher
Informa UK Limited
Online
2017-03-23
DOI
10.1080/14728222.2017.1310842
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
- (2017) Renata Ferrarotto et al. JOURNAL OF CLINICAL ONCOLOGY
- Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398
- (2017) Jharna Datta et al. MOLECULAR CANCER THERAPEUTICS
- Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+Gastric Cancer Stem Cells
- (2017) Samarpita Barat et al. Stem Cells Translational Medicine
- Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties
- (2016) Shuichi Aoki et al. BMC CANCER
- The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis
- (2016) L. Astudillo et al. CANCER RESEARCH
- Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
- (2016) Wantae Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
- (2016) Chiara Ambrogio et al. NATURE MEDICINE
- Notch signalling in context
- (2016) Sarah J. Bray NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression
- (2016) Chiung-Kuei Huang et al. PLoS One
- Notch3 drives development and progression of cholangiocarcinoma
- (2016) Rachel V. Guest et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polyclonal SecondaryFGFR2Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
- (2016) Lipika Goyal et al. Cancer Discovery
- Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
- (2016) L Che et al. Oncogenesis
- Glycosylated Notch and Cancer
- (2016) Shanmugasundaram Pakkiriswami et al. Frontiers in Oncology
- Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand
- (2016) Somkiattiyos Woradet et al. PLoS One
- Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma
- (2016) Maiko Terada et al. Scientific Reports
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells
- (2015) J. Zhang et al. CANCER RESEARCH
- Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
- (2015) A. Moeini et al. CLINICAL CANCER RESEARCH
- Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma
- (2015) Hajime Matsushima et al. DIGESTIVE AND LIVER DISEASE
- Differential effects of targeting Notch receptors in a mouse model of liver cancer
- (2015) Erik G. Huntzicker et al. HEPATOLOGY
- Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma
- (2015) Steven Koprowski et al. JOURNAL OF SURGICAL RESEARCH
- Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis
- (2015) Tong-Chun Xue et al. TUMOR BIOLOGY
- Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver
- (2015) Xiaolei Li et al. Oncotarget
- Molecular Signalling in Hepatocellular Carcinoma: Role of and Crosstalk among Wnt/β-Catenin, Sonic Hedgehog, Notch and Dickkopf-1
- (2015) Alexandros Giakoustidis et al. Canadian Journal of Gastroenterology and Hepatology
- Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
- (2015) Michele Simbolo et al. Oncotarget
- Hepatocytes, Rather than Cholangiocytes, Can Be the Major Source of Primitive Ductules in the Chronically Injured Mouse Liver
- (2014) Sayaka Sekiya et al. AMERICAN JOURNAL OF PATHOLOGY
- Abstract P2-14-04: A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer.
- (2014) JA Means-Powell et al. CANCER RESEARCH
- The Notch Pathway Inhibits TGF Signaling in Breast Cancer through HEYL-Mediated Crosstalk
- (2014) L. Han et al. CANCER RESEARCH
- Hippo Pathway Activity Influences Liver Cell Fate
- (2014) Dean Yimlamai et al. CELL
- Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
- (2014) Branden D. Tarlow et al. Cell Stem Cell
- Wnt–Notch signalling crosstalk in development and disease
- (2014) Giovanna M. Collu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer
- (2014) R. A. Previs et al. CLINICAL CANCER RESEARCH
- A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma
- (2014) Arihiro Aihara et al. HEPATOLOGY
- Emerging roles of Notch signaling in liver disease
- (2014) Fabian Geisler et al. HEPATOLOGY
- A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
- (2014) Ana De Jesus-Acosta et al. INVESTIGATIONAL NEW DRUGS
- Therapeutic modulation of Notch signalling — are we there yet?
- (2014) Emma R. Andersson et al. NATURE REVIEWS DRUG DISCOVERY
- Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer
- (2014) Andrew T. Baker et al. Frontiers in Oncology
- The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
- (2013) Qi Zhou et al. BMC CANCER
- A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
- (2013) Steffen Zender et al. CANCER CELL
- Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma
- (2013) Darjus Felix Tschaharganeh et al. GASTROENTEROLOGY
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- Robust cellular reprogramming occurs spontaneously during liver regeneration
- (2013) K. Yanger et al. GENES & DEVELOPMENT
- Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability
- (2013) Utpal B Pajvani et al. NATURE MEDICINE
- Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
- (2013) D Sia et al. ONCOGENE
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
- (2013) Naoko Takebe et al. PHARMACOLOGY & THERAPEUTICS
- Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo
- (2013) Mona El Khatib et al. PLoS One
- Operative Management of Cholangiocarcinoma
- (2013) Ser Lee et al. SEMINARS IN LIVER DISEASE
- Notch signalling beyond liver development: Emerging concepts in liver repair and oncogenesis
- (2013) Carola Maria Morell et al. Clinics and Research in Hepatology and Gastroenterology
- S1-5: Modulation of Cancer and Stem Cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine Therapy for Early Stage ER+ Breast Cancer.
- (2012) KS Albain et al. CANCER RESEARCH
- Notch Signaling Is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice
- (2012) Augusto Villanueva et al. GASTROENTEROLOGY
- Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
- (2012) Mina Komuta et al. HEPATOLOGY
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
- (2012) Sayaka Sekiya et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
- (2012) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease
- (2012) Luke Boulter et al. NATURE MEDICINE
- sox9b Is a Key Regulator of Pancreaticobiliary Ductal System Development
- (2012) Marion Delous et al. PLoS Genetics
- Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
- (2011) K Pandya et al. BRITISH JOURNAL OF CANCER
- The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells
- (2011) Simone Brabletz et al. EMBO JOURNAL
- Alagille syndrome: pathogenesis, diagnosis and management
- (2011) Peter D Turnpenny et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
- (2011) Jesper B. Andersen et al. GASTROENTEROLOGY
- Risk factors for cholangiocarcinoma
- (2011) Gia L. Tyson et al. HEPATOLOGY
- Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment
- (2011) Ya-yong Li et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- Notch post-translationally regulates β-catenin protein in stem and progenitor cells
- (2011) Chulan Kwon et al. NATURE CELL BIOLOGY
- Clinical diagnosis and staging of cholangiocarcinoma
- (2011) Boris Blechacz et al. Nature Reviews Gastroenterology & Hepatology
- Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome
- (2010) J. J. Hofmann et al. DEVELOPMENT
- Organogenesis and Development of the Liver
- (2010) Karim Si-Tayeb et al. DEVELOPMENTAL CELL
- Convergence of Notch and β-catenin signaling induces arterial fate in vascular progenitors
- (2010) Kohei Yamamizu et al. JOURNAL OF CELL BIOLOGY
- Evaluation of Selective -Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
- (2010) P. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
- (2010) Miguel Aste-Amézaga et al. PLoS One
- The Multiple Facets of Ubiquitination in the Regulation of Notch Signaling Pathway
- (2010) Stéphanie Le Bras et al. TRAFFIC
- Intrahepatic Cholangiocarcinoma
- (2009) Itaru Endo et al. ANNALS OF SURGERY
- The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival
- (2009) Sae-Byeol Choi et al. ANNALS OF SURGICAL ONCOLOGY
- Down-regulation of the Notch pathway mediated by a γ-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia
- (2009) J Tammam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Notch signaling controls liver development by regulating biliary differentiation
- (2009) Y. Zong et al. DEVELOPMENT
- Notch Signaling: The Core Pathway and Its Posttranslational Regulation
- (2009) Mark E. Fortini DEVELOPMENTAL CELL
- Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications
- (2009) Ji-Liang Li Frontiers in Bioscience-Landmark
- Mechanisms of Liver Development: Concepts for Understanding Liver Disorders and Design of Novel Therapies
- (2009) Frédéric P. Lemaigre GASTROENTEROLOGY
- Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice
- (2009) Jan S. Tchorz et al. HEPATOLOGY
- Direct inhibition of the NOTCH transcription factor complex
- (2009) Raymond E. Moellering et al. NATURE
- Substrate specificity of γ-secretase and other intramembrane proteases
- (2008) A. J. Beel et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hes genes and neurogenin regulate non-neural versus neural fate specification in the dorsal telencephalic midline
- (2008) I. Imayoshi et al. DEVELOPMENT
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
- (2008) Boris Blechacz et al. HEPATOLOGY
- ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
- (2008) C Osipo et al. ONCOGENE
- Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
- (2008) S.A. Khan et al. HPB
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now